There are presently massive shifts occurring in the competitive global landscape of health, and particularly in the life sciences. As we approach 2015, it is imperative that leaders in the health space understand the trends and shifts happening around them, not only in the US, but also in international markets, cities and service lines.
With unparalleled connectivity, evolving demographics, impressive growth in patent applications in emerging markets and pharmaceutical demand changes worldwide, there is no doubt that hospital leadership, policymakers, manufacturers, inventors and clinicians in America need to know what is in the pipeline for 2015 and beyond. Using the 2014 Global Life Sciences Cluster Report from JLL, here are the top 7 trends you need to know for success in 2015.
- Global Innovation: While both North America and Europe continue to have the most life science Patent Cooperation Treaty (PCT) applications per year (41% and 31% share, respectively), major shifts are occurring. PCT applications, an international measure of innovative output, in Asia, Latin America and the Caribbean are increasing, with the gap forecasted to continue closing. This trend, in part, can be attributed to the shift from broad, chronic disease biological maturity in developed countries to developing countries. In turn, many advanced cities and companies are transitioning to specific, personalized biologics and care. For example,biosimilars are taking root in the US and EU, while diabetes has become a primary focus of the Middle East and North Africa.